ArticleOncotarget2014

Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo.

Anna Goc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.